UM: Cancer

By

The New York Times reports on a UM study that examined why some women decide not to take the drug tamoxifen, even when told that it could prevent breast cancer. The article quotes Angela Fagerlin, UM associate professor of internal medicine and the lead author of the study, published in the journal Breast Cancer Research and Treatment: “When the numbers were laid out for them in a way they could clearly understand, they weren’t interested in taking tamoxifen. They didn’t think the benefits of tamoxifen outweighed the risks.” [Source]